Zhejiang Tianyu Pharmaceutical Co Ltd (300702) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.063x

Based on the latest financial reports, Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a cash flow conversion efficiency ratio of 0.063x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥233.18 Million ≈ $34.12 Million USD) by net assets (CN¥3.72 Billion ≈ $544.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Zhejiang Tianyu Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Zhejiang Tianyu Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Zhejiang Tianyu Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Tianyu Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Tianyu Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 300702 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
CATARC Automotive Proving Ground Co.Ltd. SHE:301215	N/A
Wah Lee Industrial Corp TW:3010	0.015x
Elecon Engineering Company Limited NSE:ELECON	0.072x
Heilongjiang Publishing & Media Co Ltd SHG:605577	0.034x
Tianjin Benefo Tejing Electric Co Ltd SHG:600468	0.001x
Citic Press Corp SHE:300788	0.070x
Huaku Development Co Ltd TW:2548	-0.167x
MetroCity Bankshares NASDAQ:MCBS	-0.062x

Annual Cash Flow Conversion Efficiency for Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2025. View 300702 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.64 Billion ≈ $532.59 Million	CN¥473.57 Million ≈ $69.30 Million	0.130x	+32.05%
2024-12-31	CN¥3.50 Billion ≈ $511.83 Million	CN¥344.64 Million ≈ $50.43 Million	0.099x	+882.72%
2023-12-31	CN¥3.49 Billion ≈ $510.37 Million	CN¥-43.90 Million ≈ $-6.42 Million	-0.013x	+9.66%
2022-12-31	CN¥3.50 Billion ≈ $511.43 Million	CN¥-48.70 Million ≈ $-7.13 Million	-0.014x	+80.29%
2021-12-31	CN¥3.71 Billion ≈ $542.77 Million	CN¥-262.23 Million ≈ $-38.37 Million	-0.071x	-140.30%
2020-12-31	CN¥3.55 Billion ≈ $519.00 Million	CN¥622.18 Million ≈ $91.04 Million	0.175x	-16.47%
2019-12-31	CN¥2.04 Billion ≈ $298.10 Million	CN¥427.84 Million ≈ $62.61 Million	0.210x	+286.63%
2018-12-31	CN¥1.45 Billion ≈ $211.66 Million	CN¥78.57 Million ≈ $11.50 Million	0.054x	-20.98%
2017-12-31	CN¥1.29 Billion ≈ $188.43 Million	CN¥88.52 Million ≈ $12.95 Million	0.069x	-74.66%
2016-12-31	CN¥607.31 Million ≈ $88.87 Million	CN¥164.74 Million ≈ $24.11 Million	0.271x	+811.67%
2015-12-31	CN¥495.77 Million ≈ $72.55 Million	CN¥14.75 Million ≈ $2.16 Million	0.030x	-83.12%
2014-12-31	CN¥456.22 Million ≈ $66.76 Million	CN¥80.44 Million ≈ $11.77 Million	0.176x	+101.33%
2013-12-31	CN¥453.68 Million ≈ $66.39 Million	CN¥39.73 Million ≈ $5.81 Million	0.088x	--

About Zhejiang Tianyu Pharmaceutical Co Ltd

SHE:300702 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.02 Billion

CN¥6.98 Billion CNY

Market Cap Rank

#8850 Global

#2145 in China

Share Price

CN¥20.05

Change (1 day)

-3.51%

52-Week Range

CN¥18.09 - CN¥27.37

All Time High

CN¥69.67